Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v2-FR
Language English French
Date Updated 2017-08-04 2017-07-24
Drug Identification Number 02362759 02362759
Brand name GD-AMLODIPINE/ATORVASTATIN GD-AMLODIPINE/ATORVASTATIN
Common or Proper name GD-Amlodipine/Atorvastatin GD-Amlodipine/Atorvastatin
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients AMLODIPINE ATORVASTATIN AMLODIPINE ATORVASTATIN
Strength(s) 5MG 10MG 5MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 90s 90s
ATC code C10BX C10BX
ATC description LIPID MODIFYING AGENTS, COMBINATIONS LIPID MODIFYING AGENTS, COMBINATIONS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2017-07-19 2017-07-19
Actual start date
Estimated end date 2017-08-03 2017-08-04
Actual end date 2017-08-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Resolved August 3, 2017
Health Canada comments